معلومات الادوية وادلة العلاج

Lumakras (Sotorasib) in combination with Vectibix (Panitumumab) FDA Approved for Metastatic Colorectal Cancer with KRAS G12C Mutation news.cancerconnect.com

Dr Fakih on the FDA Approval of Sotorasib Plus Panitumumab for KRAS G12C–Mutated mCRC OncLive

Dabrafenib plus trametinib in BRAFV600E -mutated rare cancers: the phase 2 ROAR trial Nature

KRYSTAL-10 at ESMO GI 2026: Adagrasib Plus Cetuximab vs Chemotherapy in KRAS G12C-Mutated mCRC Oncodaily